07/03/2011 (Agence Europe) - EU authorises marketing of first remedy for pulmonary fibrosis. US biotech laboratory InterMune announced on Thursday 4 March that the European Commission has authorised the marketing of the first medicine to treat idiopathic pulmonary fibrosis (IPF), a progressive illness for which there is no known cure. According to InterMune, this is the first treatment for an illness from which more than 100,000 people in Europe suffer. The authorisation will allow Esbriet...